Current press releases

Find current press releases from Dräger. For past press releases please visit our archives.

press_release_fallback.jpg

February 18, 2010

Dräger reporting significant increase in Q4 profits

  • Q4 EBIT reached EUR 51.7 million (Q1-Q3 2009: EUR 28.4 million)
  • Orders on hand at record level
  • Turnaround program delivering considerably higher savings

press_release_fallback.jpg

December 29, 2009

Dräger buys back Siemens stake in Dräger Medical AG & Co. KG

Drägerwerk AG & Co. KGaA, Lübeck, is to purchase the 25 percent minority stake in Dräger Medical AG & Co. KG held by Siemens AG, Munich. The Managing Board of Siemens AG approved the move, as did the corresponding bodies at Drägerwerk AG & Co. KGaA.

press_release_fallback.jpg

December 22, 2009

Dräger savings on track, Lübeck site strengthened

  • Respiratory Care strategic business field to be pooled in Lübeck in future
  • New building for Infrastructure Projects strategic business field
  • Production increases workforce in Lübeck

press_release_fallback.jpg

December 21, 2009

Supervisory Board extends Stefan Dräger’s Executive Board contract

  • Dr. Herbert Fehrecke appointed Vice Chairman of the Executive Board

press_release_fallback.jpg

November 05, 2009

Third quarter of 2009:
Order intake and net sales increase

  • H1N1 virus boosts positive development
  • Earnings in third quarter increase year-on-year
  • Currency effects impact full year earnings
  • Operating cash flow significantly up on prior year figure
  • Turnaround program records its first successes

press_release_fallback.jpg

August 06, 2009

Second quarter of 2009:
Dräger increases order intake and net sales

  • Currency effects and change in product mix impact earnings
  • R&D expenditure rises to 8.4 percent of net sales
  • Free cash flow improved
  • Net debt lowered
  • Turnaround program being implemented

press_release_fallback.jpg

August 06, 2009

Second quarter of 2009:
Dräger increases order intake and net sales

  • Currency effects and change in product mix impact earnings
  • R&D expenditure rises to 8.4 percent of net sales
  • Free cash flow improved
  • Net debt lowered
  • Turnaround program being implemented

press_release_fallback.jpg

June 15, 2009

Dräger countering negative earnings trend by launching turnaround program

  • Reduction in non-personnel and personnel costs as well as optimization of revenues planned
  • Pact for Jobs of all employees envisaged
  • Reduction in headcount expected
  • 400 individual measures in all areas of the Company
  • The measure’s capacity amounts to EUR 100 million
  • Implementation starting in July
  • Continuingly high investments into product development

press_release_fallback.jpg

March 06, 2009

Annual accounts press conference 2009

Lübeck, Germany – Drägerwerk AG & Co. KGaA finished fiscal year 2008 with an increase in net sales and stable order intake. The Company also achieved its revised earnings forecast. In 2009, the Company expects net sales to decrease by up to 5 percent.

iF Award

March 9, 2009

Superior Product Design

Not one, but two Dräger products received the iF product design award in 2009: The Ponta beam system and the Infinity C700 for IT workstation. A total of 2,808 products from 39 countries were submitted. The international selection committee awarded 802 labels for superior product design. These two medical devices were among the first Dräger products developed according to the company’s current design guidelines.

press_release_fallback.jpg

March 6, 2009

Dräger achieves revised forecast

Net sales up 5.8 percent to EUR 1,924.5 million. EBIT (before non-recurring expenses) as expected at EUR 130.5 million. Non-recurring expenses of EUR 24.7 million, as planned. Increase in equity to 31.3 percent. Dividend of EUR 0.35 per preferred share proposed

press_release_fallback.jpg

February 1, 2009

Dräger reviewing the buy-back of the Siemens stake

Drägerwerk AG & Co. KGaA (Dräger) is reviewing the buy-back of the 25 percent stake currently held by Siemens AG (Siemens) in Dräger Medical AG & Co. KG. This would increase the stake Dräger holds in the medical subsidiary to 100 percent. Dräger is currently involved in negotiations on funding.

pr_92a_alcotest_7510

November 11, 2008

New alcohol measuring instrument: The Dräger Alcotest 7510

The new Dräger Alcotest 7510 has been designed to provide precise measurement of breath alcohol concentrations, even when residual mouth alcohol may be present. Ergonomic and robust, this hand-held instrument is suitable for a wide range of applications and provides detailed test results. Intended for use in temperatures from -10°C to + 50°C, it delivers fast and accurate measurements.

pr_86a_draeger_pir_7000

October 1, 2008

New Infrared Gas Transmitters from Dräger. Dräger PIR 7000 and Dräger PIR 7200

Dräger has further extended its comprehensive range of explosion proof fixed gas detection systems with two new infrared (IR) gas transmitters. Ideal for use throughout industry and ensuring no false alarms, the Dräger PIR 7000 provides continuous monitoring of flammable gases and vapours, whilst the Dräger PIR 7200 is designed to monitor carbon dioxide.